https://www.gsk.com/en-gb/media/press-releases/data-support-avandia-rosiglitazone-maleate-cardiovascular-safety-profile/
The U.S. Food and Drug Administration (FDA) today posted a comprehensive review conducted by GlaxoSmithKline (GSK).
rosiglitazone maleatesafety profiledatasupportavandia
https://www.marketresearchfuture.com/reports/dibutyl-maleate-market-41722
Dibutyl Maleate Market worth USD 0.75 Billion in 2024, forecasted to hit USD 1.21 Billion by 2035, growing at 4.43% CAGR.
dibutyl maleatemarket sizedbmindustryreport